# Aaron Nelson

> Aaron Nelson is a Series A investor at Novartis Venture Fund (Boston) backing Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Novartis Venture Fund](https://shizune.co/investors/profile/novartis-venture-fund)
- Location: Boston, United States
- Total investments: 1
- Last investment: Jun 2024
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/aaron-nelson-a021388
- X (Twitter): https://twitter.com/aaronlnelson
- Website: https://x.com/aaronlnelson

Aaron Nelson is a Series A investor at Novartis Venture Fund in Boston focused on Biotechnology. Aaron Nelson - Principal & Managing Director @ Novartis Venture Fund

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Averna Therapeutics | Exsilio's method is based on naturally occurring genetic elements that can accurately insert new genes into cells via RNA intermediate templates. Exsilio employs predictive in-silico modeling and wet lab-based experiments to create such elements for accurate insertion of therapeutic genes into safe harbor regions of disease-relevant cells. | $85M | Series A | Jun 25, 2024 |  |

1 of 1 investments shown.

## Co-investors
- [Arc Ventures](https://shizune.co/investors/profile/arc-ventures-b6d5) — VC Fund, 1 deal together
- [CRISPR Therapeutics](https://shizune.co/investors/profile/crispr-therapeutics) — VC Fund, 1 deal together
- [Deep-Insight](https://shizune.co/investors/profile/deep-insight-4989) — VC Fund, 1 deal together
- [Deep Insight](https://shizune.co/investors/profile/deep-insight-6269) — VC Fund, 1 deal together
- [Delos Capital](https://shizune.co/investors/profile/delos-capital-%E5%BA%B7%E7%A6%A7%E5%85%A8%E7%90%83%E6%8A%95%E8%B3%87%E5%9F%BA%E9%87%91) — VC Fund, 1 deal together
- [Innovation Endeavors](https://shizune.co/investors/profile/innovation-endeavors) — VC Fund, 1 deal together

## About Novartis Venture Fund

VC Fund · Basel, Switzerland

Novartis Venture Fund's primary focus is on the development of novel therapeutics and platforms. They balance the therapeutic focus with investments in medical devices, diagnostics, or drug delivery systems. In their investments, they look for unmet needs and clinical impact, novel proprietary science, an understanding of mechanism, managementand board experience, and capital efficiency in the program.Novartis Venture Fund prefers to have their initial investment at the early stage to build the company and follow with additional investment in pace with the company's progress. Their approach involves larger focused investments, with anticipation of total investments up to USD 30 to 50 million per company over its life, but it can be as little as 100,000 USD to get started. They plan to increase their activities to lead or co-lead deals further and remain open to participating in larger syndicates.

5 contacts available at Novartis Venture Fund.

| Name | Title | Profile |
| --- | --- | --- |
| Aaron Nelson | Principal & Managing Director | https://shizune.co/investors/profile/aaron-nelson |
| Anja König | Global Head Novartis Venture Fund | https://shizune.co/investors/profile/dr-anja-knig |
| Bart Dzikowski | Managing Director, Head of Transactions & Legal | https://shizune.co/investors/profile/bart-dzikowski |
| Florent Gros | Managing Director | https://shizune.co/investors/profile/florent-gros |
| Florent Gros | Managing Director | https://shizune.co/investors/profile/florent-gros-4c33 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Aaron Nelson invest in?

Aaron Nelson invests primarily in Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Aaron Nelson last invest?

The most recent investment recorded for Aaron Nelson closed in Jun 2024. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co